SECTORAL ASSET MANAGEMENT INC logo

SECTORAL ASSET MANAGEMENT INC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for SECTORAL ASSET MANAGEMENT INC with $159.6M in long positions as of Q3 2025, 74% allocated to Healthcare, and 36% concentrated in top 10 positions.

Portfolio Value
$159.6M
Top 10 Concentration
36%
Top Sector
Healthcare (74%)
US Exposure
95%
Market Cap Focus
Small Cap
Countries
6

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 73.80%HealthcareETF: 2.10%
Healthcare
73.80%
ETF
2.10%

Industry Breakdown

9 industries across all sectors

Biotechnology: 44.59%BiotechnologyDrug Manufacturers - General: 14.21%Drug Manufacturers - GeneralMedical - Devices: 5.40%Medical - Healthcare Plans: 3.85%Medical - Diagnostics & Research: 3.33%ETF: 2.14%Medical - Instruments & Supplies: 1.61%Medical - Healthcare Information Services: 0.57%Drug Manufacturers - Specialty & Generic: 0.26%
Biotechnology
Healthcare
44.59%
Drug Manufacturers - General
Healthcare
14.21%
Medical - Devices
Healthcare
5.40%
Medical - Healthcare Plans
Healthcare
3.85%
Medical - Diagnostics & Research
Healthcare
3.33%
ETF
ETF
2.14%
Medical - Instruments & Supplies
Healthcare
1.61%
Medical - Healthcare Information Services
Healthcare
0.57%
Drug Manufacturers - Specialty & Generic
Healthcare
0.26%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 13.65%Mega Cap (> $200B)Large Cap ($10B - $200B): 22.91%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 7.36%Small Cap ($300M - $2B): 33.67%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 9.24%Micro Cap ($50M - $300M)Nano Cap (< $50M): 2.64%N/A (ETF or Unknown): 10.54%N/A (ETF or Unknown)
Mega Cap (> $200B)
13.65%
Large Cap ($10B - $200B)
22.91%
Mid Cap ($2B - $10B)
7.36%
Small Cap ($300M - $2B)
33.67%
Micro Cap ($50M - $300M)
9.24%
Nano Cap (< $50M)
2.64%
N/A (ETF or Unknown)
10.54%

Portfolio Concentration

Top 10 Holdings %
35.56%
Top 20 Holdings %
56.62%
Top 50 Holdings %
90.22%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
94.54%
International
5.46%
Countries
6
Largest Int'l Market
Germany - 2.99%
United States of America
94.54% ($150.8M)
75 holdings
Germany
2.99% ($4.8M)
1 holdings
Netherlands
1.81% ($2.9M)
2 holdings
United Kingdom
0.47% ($756.6K)
1 holdings
Ireland
0.19% ($295.8K)
1 holdings
Switzerland
0.00% ($6.9K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
9.3 quarters
Avg. Top 20
7.7 quarters
Avg. All Positions
11.6 quarters
Median Holding Period
10 quarters
Persistence Rate
67.9%
Persistent Holdings Weight
60.01%
Persistent Positions
55
Longest Held
BioMarin Pharmaceuticals Inc logo
BioMarin Pharmaceuticals IncBMRN - 49 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
3.38%
Avg. Position Weight
1.23%
Largest Position
Contineum Therapeutics, Inc. Class A Common Stock logo
Contineum Therapeutics, Inc. Class A Common StockCTNM - 5.90%
Largest Ownership Stake
Contineum Therapeutics, Inc. Class A Common Stock logo
Contineum Therapeutics, Inc. Class A Common StockCTNM - 2.86%
Avg. Ownership Stake
0.47%
Ownership Stake >5%
0
Ownership Stake >1%
5

Historical (Since Q2 2013)

Avg. New Position
0.95%
Avg. Ownership Stake
0.55%
Largest Position
LENZ Therapeutics, Inc. Common Stock logo
LENZ Therapeutics, Inc. Common StockLENZ - 19.68% (Q1 2025)
Largest Ownership Stake
Aprea Therapeutics, Inc. Common stock logo
Aprea Therapeutics, Inc. Common stockAPRE - 6.85% (Q1 2020)

Portfolio Turnover

Current Quarter

Turnover Ratio
27.1%
Value Traded
$43.26M
Positions Added
1
Positions Exited
16

Historical (Since Q2 2013)

Avg. Turnover Ratio
25.1%
Avg. Positions Added
12
Avg. Positions Exited
16
Highest Turnover
77.4%
Q2 2016
Lowest Turnover
10.6%
Q3 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.